These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8239313)

  • 1. X-ray diffraction analysis of brain lipid membrane structure in Alzheimer's disease and beta-amyloid peptide interactions.
    Mason RP; Shoemaker WJ; Shajenko L; Herbette LG
    Ann N Y Acad Sci; 1993 Sep; 695():54-8. PubMed ID: 8239313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol.
    Mason RP; Shoemaker WJ; Shajenko L; Chambers TE; Herbette LG
    Neurobiol Aging; 1992; 13(3):413-9. PubMed ID: 1625771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis.
    Mason RP; Estermyer JD; Kelly JF; Mason PE
    Biochem Biophys Res Commun; 1996 May; 222(1):78-82. PubMed ID: 8630078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxidative stress on membrane structure: small-angle X-ray diffraction analysis.
    Mason RP; Walter MF; Mason PE
    Free Radic Biol Med; 1997; 23(3):419-25. PubMed ID: 9214578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.
    Walter MF; Mason PE; Mason RP
    Biochem Biophys Res Commun; 1997 Apr; 233(3):760-4. PubMed ID: 9168929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.
    Eckert GP; Cairns NJ; Maras A; Gattaz WF; Müller WE
    Dement Geriatr Cogn Disord; 2000; 11(4):181-6. PubMed ID: 10867442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular membrane interactions of a phospholipid metabolite. Implications for Alzheimer's disease pathophysiology.
    Mason RP; Trumbore MW; Pettegrew JW
    Ann N Y Acad Sci; 1996 Jan; 777():368-73. PubMed ID: 8624114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane interactions of a phosphomonoester elevated early in Alzheimer's disease.
    Mason RP; Trumbore MW; Pettegrew JW
    Neurobiol Aging; 1995; 16(4):531-9. PubMed ID: 8544902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing membrane bilayer interactions of 1,4-dihydropyridine calcium channel blockers. Implications for aging and Alzheimer's disease.
    Mason RP
    Ann N Y Acad Sci; 1994 Dec; 747():125-39. PubMed ID: 7847667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease.
    Torres M; Price SL; Fiol-Deroque MA; Marcilla-Etxenike A; Ahyayauch H; Barceló-Coblijn G; Terés S; Katsouri L; Ordinas M; López DJ; Ibarguren M; Goñi FM; Busquets X; Vitorica J; Sastre M; Escribá PV
    Biochim Biophys Acta; 2014 Jun; 1838(6):1680-92. PubMed ID: 24374316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis.
    Tulenko TN; Chen M; Mason PE; Mason RP
    J Lipid Res; 1998 May; 39(5):947-56. PubMed ID: 9610760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide model helices in lipid membranes: insertion, positioning, and lipid response on aggregation studied by X-ray scattering.
    Schneggenburger PE; Beerlink A; Weinhausen B; Salditt T; Diederichsen U
    Eur Biophys J; 2011 Apr; 40(4):417-36. PubMed ID: 21181143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis alters the composition, structure and function of arterial smooth muscle cell plasma membranes.
    Chen M; Mason RP; Tulenko TN
    Biochim Biophys Acta; 1995 Oct; 1272(2):101-12. PubMed ID: 7548233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The separate profile structures of the functional calcium pump protein and the phospholipid bilayer within isolated sarcoplasmic reticulum membranes determined by X-ray and neutron diffraction.
    Herbette L; DeFoor P; Fleischer S; Pascolini D; Scarpa A; Blasie JK
    Biochim Biophys Acta; 1985 Jul; 817(1):103-22. PubMed ID: 3159429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol modulates amyloid beta-peptide's membrane interactions.
    Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.
    Fabelo N; Martín V; Marín R; Moreno D; Ferrer I; Díaz M
    Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of membrane lipid composition on the structure and activity of γ-secretase.
    Aguayo-Ortiz R; Straub JE; Dominguez L
    Phys Chem Chem Phys; 2018 Nov; 20(43):27294-27304. PubMed ID: 30357233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions.
    Lau TL; Ambroggio EE; Tew DJ; Cappai R; Masters CL; Fidelio GD; Barnham KJ; Separovic F
    J Mol Biol; 2006 Feb; 356(3):759-70. PubMed ID: 16403524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.